Mayo Endoscopic Score Grades in IBD
The Mayo Endoscopic Score (MES) is a 4-point scale (0-3) used specifically for ulcerative colitis that grades endoscopic disease activity based on the most inflamed segment of the colon. 1
MES Grading System
The Mayo Endoscopic Score evaluates vascular patterns, erythema, friability, erosions, ulcerations, and bleeding in the most inflamed part of the colon 1:
- Grade 0 (Normal or Inactive Disease): Normal mucosa, no visible inflammation
- Grade 1 (Mild Disease): Erythema, decreased vascular pattern, mild friability
- Grade 2 (Moderate Disease): Marked erythema, absent vascular pattern, moderate friability, erosions
- Grade 3 (Severe Disease): Spontaneous bleeding, ulcerations
Clinical Significance and Interpretation
Mucosal healing is defined as an MES of 0 or 1, which has been associated with significantly lower colectomy rates in clinical trials 1. In the ACT-1 and ACT-2 infliximab trials, patients achieving MES 0-1 at week 8 had substantially reduced need for colectomy beyond 54 weeks 1.
Endoscopic improvement in clinical trials is commonly defined as MES 0/1, making this the target threshold for treatment response 1, 2.
Important Caveats
Validation Status
The MES has not been formally validated despite its widespread use in clinical trials 1, 2. This is a critical limitation that clinicians should recognize.
Interobserver Variability
Agreement between observers can vary markedly, ranging from high agreement to only fair or moderate agreement 1, 2. The subjective interpretation of friability is particularly problematic and represents a key weakness of this scoring system 2.
Scoring Methodology
Only the most inflamed segment determines the overall score 2. This means the MES does not capture the extent of disease or improvements in less severely affected areas, potentially missing clinically meaningful changes 3.
Alternative Considerations
While the MES remains the most widely used endoscopic score in UC clinical trials 1, 2, the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) is a validated alternative that may be more accurate for assessing disease severity 2. The UCEIS scores three parameters (vascular pattern 0-2, bleeding 0-3, erosions/ulcers 0-2) for a total of 0-8 points and excludes the problematic friability assessment 1, 2.
Note: The Mayo Endoscopic Score is specific to ulcerative colitis, not Crohn's disease. For Crohn's disease, different scoring systems (CDEIS and SES-CD) are used 1.